Jaime practices with the Mass Torts and Industry Wide Litigation Practice Group, the Medical and Life Sciences Industry Team, the First Response Emergency, Crisis and Disaster Team and the Cybersecurity Team. Her practice focuses on the defense of complex product liability, commercial and toxic tort disputes, with particular emphasis on high-exposure catastrophic injury and property damage claims against manufacturers and distributors of commercial and consumer products and equipment. She routinely defends and counsels entities involved in the chain of supply of retail and consumer goods, construction and industrial products and equipment, personal protective equipment, automotive products, plastics and phenolic molding compounds and drugs such as Diethylstilbestrol (DES). Further, Jaime helps clients with crisis management response by documenting incident scenes, corresponding with government agencies in the event of investigation, and defending resulting litigation.
Jaime works hard to ensure the efficient handling of all aspects of litigation, from early settlement negotiations and mediation, to conducting aggressive motion practice, depositions, and trial preparation. In addition, she collaborates with expert witnesses to develop sophisticated scientific and state of the art defenses in preparation for trial.
Jaime also routinely counsels clients on a broad array of issues impacting their businesses, including best practices for marketing products, drafting of disclaimers, labels, and package inserts and literature to avoid and defend future litigation; initiating product recalls; and preservation of evidence in pre-litigation matters. She advises clients on liability issues that have arisen during the COVID-19 pandemic, particularly with regard to in-demand products such as masks, respirators, and hand sanitizers. Moreover, she counsels clients on compliance with safety, advertising and telemarketing regulations, and helps clients develop internal marketing, training and record-keeping practices. She is well-versed in responding to sensitive requests for information from governmental and private consumer protection entities.
RECENT PUBLICATIONS + SPEAKING ENGAGEMENTS
- FDA and FTC Take Action Regarding Pandemic-Related Products (Legal Alert, November 2020).
- The Impact of Unconscious Bias and Microaggressions on Diversity in the Workplace (DRI Virtual Young Lawyers Seminar, October 2020).
- FDA’s Emergency Use Authorization Expands Class of Mask Manufacturers and Distributors Entitled to Immunity (Legal Alert, April 2020).
- NIOSH-Approved Masks Defined as Covered Countermeasures for Liability Immunity Under Amended PREP Act Declaration (Legal Alert, April 2020).
- Appellate Division Chips Away At Specific Causation Requirements in Asbestos Cases (Legal Alert, April 2020).
- Government Issues Immunity to Liability for COVID-19 Countermeasures (Legal Alert, March 2020).
- DRI’s Product Liability Compendium: 2019 Second Circuit Product Liability Cases of Note (February 2020).
- DRI's For the Defense: Mediation Tips for Young Lawyers (October 2019).
- DRI Young Lawyers Seminar: Inspecting and Preserving Evidence During Discovery and Dealing with Spoliation in Litigation (CLE, June 2019).
- "Sellers" Beware: Online Marketplaces Could See Increased Liability for Allegedly Defective Products (Legal Alert, June 2019).
- Valuing Damages in Tort Actions (CLE, July 2018).
- DRI's Raising the Bar: Tips and Tricks for Preservation and Inspection of Evidence During Discovery (June 2017).
- Appellate Court Affirms That Parker Governs Expert Testimony in Asbestos Cases (Legal Alert, April 2017).
- Appellate Court Grants Summary Judgment in Product Liability Lawsuit (Legal Alert, March 2017).
- Cybersecurity Litigation: What the Hack do we do? (CLE, September 2016).
- House Votes to Authorize the Nation’s Premier Cybercrime Training Center (Legal Alert, December 2015).
- DRI’s For the Defense: Attacking Justiciability of Cybersecurity Claims in the Products Liability Context (November 2015).
- Appellate Division Holds That Demolition Work Involving Previously-Installed Product Does Not Constitute Foreseeable Use of the Product as a Matter of Law (Legal Alert, June 2015).
